Calamos Advisors’s EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant EQHA.U Stock Holding History

Calamos Advisors’s Portfolio EQHA.U Stock Details EQHA.U Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-300,700	Closed	-$2.82M	–	1515
2022 Q2	$2.82M	Hold	300,700	–	–	0.01%	860
2022 Q1	$2.98M	Hold	300,700	–	–	0.01%	837
2021 Q4	$2.98M	Hold	300,700	–	–	0.01%	826
2021 Q3	$3.01M	Hold	300,700	–	–	0.01%	714
2021 Q2	$3M	Hold	300,700	–	–	0.01%	661
2021 Q1	$2.98M	Buy	+300,700	New	+$3.05M	0.02%	640

Other funds holding EQHA.U

BCM

Basso Capital Management Stamford, Connecticut $163M AUM 21.95% 1-Year Est. Return

CIM

Cowen Investment Management New York $12M AUM 1.47% 1-Year Est. Return

MFM

MHR Fund Management New York $1.37B AUM 68.35% 1-Year Est. Return

Wealthspring Capital West Harrison, New York $448M AUM 8.38% 1-Year Est. Return

SIA

Schechter Investment Advisors Birmingham, Michigan $1.21B AUM 8.73% 1-Year Est. Return

MTCM

Mint Tower Capital Management Amsterdam, Netherlands $1.12B AUM 19.06% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 51.91% 1-Year Est. Return

LCM

Landscape Capital Management Englewood, New Jersey $1.58B AUM 26.88% 1-Year Est. Return

Jane Street New York $777B AUM 61.18% 1-Year Est. Return

Calamos Advisors's EQHA.U Position: Q3 2022 in Review

Calamos Advisors sold out of EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant (EQHA.U) in Q3 2022, closing a stake of 300,700 shares — an estimated $2.82M sold.

Calamos Advisors first reported a position in EQHA.U in Q1 2021 and held it in 6 quarters. The position peaked at $3.01M in Q3 2021. 13 funds tracked by Wall St. Rank hold EQHA.U as of Q3 2022.

Calamos Advisors reported no remaining EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position as of Q3 2022 after selling out during the quarter.
Calamos Advisors sold 300,700 EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant shares in Q3 2022, an estimated $2.82M.
Calamos Advisors first reported a position in EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant in Q1 2021 and held it in 6 quarters.
Calamos Advisors's EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant position peaked at $3.01M in Q3 2021.
13 funds tracked by Wall St. Rank held EQ Health Acquisition Corp. Units, each consisting of one share of Class A common stock and one-half of one redeemable warrant as of Q3 2022.

Based on Calamos Advisors's 13F filing for Q3 2022, filed 24 Oct 2022.